Toggle navigation
TWunroll
TWunroll
faq
Contact US
#Biomarkers
Dr. Crystal Grant
itscrystalgrant
In honor of #BlackInGeneticsWeek I’m gonna see if I can make my research fit into a few tweets! I was drawn to epigenetics because I found the concepts of
Read more
Hannah Davis 🦈
ahandvanish
Day 2 of the NIH #LongCovid conference.First up w Dr. Carlos del Rio on social determinants of health, race, and ethnicity in #LongCovid-the pandemic has exacerbated health inequalities-this is not
Read more
Catherine Gao-Howard
CatGaoHow
1/# Excited to share our #NUCOVIDInvestigators work looking at #BAL in intubated #COVID19 patients with @NM_lung @RoganAGrant @MichaelCuttica @luisamnMD @nufeinbergmed @NU_IntMed@BavishiAvni @jarnold93 @ScottBudinger @bsinger007 & Rich
Read more
Dr. Maria-Elena Vorrath
MEVorrath
I proudly present the 2nd research article of my PhD project #PALICE published in @EGU_CP together with @iso_topel and many other fantastic colleagues.What did we find? Some #scicomm in the
Read more
victoria
victoriagraupp
If you're friends with Catholics, you may have seen posts about #nfpweek. If you know me at all, you probably know that I'm not strictly anti-birth control and I struggle
Read more
Dr Michelle Kelly-Irving
shell_ki
In our research team we work on understanding how #HealthInequalities are constructedWe've heard about Black and ethnic minority populations having worse health outcomes, as well as socially disadvantaged peopleBut HOW
Read more
Ana M Daugherty
DrAnaDaugherty
Inspired by @quantitudepod I'll start to post periodic threads that bring together cognitive neuroscience and statistics--two of my favorite topics to nerd out about.First up: How do we think about
Read more
Albert Vilella
AlbertVilella
A more polished thread on #epigenomic #biomarkers for #LiquidBiopsy and #CancerScreening: Epigenomic biomarkers are becoming more established for #LiquidBiopsy and #CancerScreening, and we have seen the big players positioning themselves
Read more
Leslie Crews
LeslieCrewsPhD
Our first paper https://authors.elsevier.com/a/1cRqD6tu0CborZ is now out @CellStemCell! With @ionispharma & the Jamieson Lab @UCSanDiegoDRM, we found that selective #antisense oligonucleotides inhibiting #IRF4 reduce disease burden &
Read more
Kevin C. Klatt, PhD, RD
KCKlatt
Tons of chatter about the new prescription omega 3 data coming forth. Lots of takes about the study designs, n3 formulations, differences across populations, variation in comparator groups. All important
Read more
Eugene Pietzak
eugene_pietzak
@TheWonkologist: All great & valid points, IMHO we as a #bladdercancer community are just so desperate for an alternative to cystectomy & @FDAOncology already set the bar so low with
Read more
Matthew J. Maurer
MaurerStats
Looking forward to moderating oral presentations on biomarkers and prognostication in aggressive #lymphoma with @SoniSmithMD on Monday morning. We have some exciting #ASH20 abstracts to discuss. https://ash.confex.com/ash/2020/webprogram/Se
Read more
Michael "Tomato" Dzakovich
MichaelTom8o
Here to interrupt your doom-scrolling with our latest pre-print about #tomato steroidal alkaloids and genetic diversity! Why care? Take 30 seconds to find out.. https://www.biorxiv.org/content/10.1101/2021.01.06.425594v1 People have known f
Read more
John Blong
JohnCBlong
Well it's #NationalPoopDay so here is a thread about our latest Paisley Caves paper! You can find our paper here (open access ) https://link.springer.com/article/10.1007/s12520-020-01160-9 Team members on twitter: @ArchaeologyLisa
Read more
Prof. Akiko Iwasaki
VirusesImmunity
Very excited to share this work by the heroic team - @carolilucas Pat Wong @sneakyvirus @tiago21bio et al on “Longitudinal analyses reveal immunological misfiring in severe COVID-19”. A thread on
Read more
Katalina Bobowik
KatalinaBobowik
I'm very excited to share the results of our new paper, now available on Biorxiv: https://biorxiv.org/cgi/content/short/2021.01.07.425684v1. Below is a thread of the main resultshttps://twitter.com/biorxivpreprint/status/134762719313285
Read more
‹
1
2
3
4
›
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree